- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01603862
ThinkingFit: Combined Physical, Cognitive and Social Treatment in Mild Cognitive Impairment (MCI) (ThinkingFit)
Piloting a Complex Intervention Involving Physical Exercise, Cognitive Training and Socialising to Delay the Onset of Dementia in Mild Cognitive Impairment
Dementia is serious problem and around 700 000 people are affected in the UK alone. Currently there is no cure however early diagnosis and effective treatment offers hope for reducing the impact. Dementia sufferers require care due to physical disability, cognitive deficits, social isolation and emotional symptoms (depression). Delaying the onset of dementia will improve quality of life for patients and reduce the cost of residential care (£42 000 per person per year).
People with mild cognitive impairment (MCI) are at high risk of developing dementia. They have impaired cognitive abilities, such as memory, but still manage their everyday activities. Studies show that 8 out of 10 people with MCI will have developed dementia 6 years after diagnosis.
Regular physical activities and performing a variety of cognitive activities reduce the risk of dementia and improves abilities and quality of life in healthy people. Therefore a combination of these activities may reduce the risk of developing dementia in MCI. The investigators want to see if they can develop a program which combines these activities in a fun and social way that gets people active and keeps them active. The aims are to improve fitness, cognition and quality of life. The investigators plan to use computers and the internet to help with the activities and to make them available to people who are isolated. Physical activity will involve walking from home, cognitive activities will be computer based games and puzzles and socialising will involve regular varied group-based activities. Participants (128) will be recruited from the UCL Derwent Memory Clinic and will complete a 26 week program. They will then be followed up yearly to monitor their progress. The main outcome of the study is engagement in the activities. The investigators will also measure fitness, cognition, quality of life and conversion to dementia.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Essex
-
Harlow, Essex, Det Forenede Kongerige, cm20 1qx
- North Essex Partnership Foundation NHS Trust
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion criteria for patients with MCI
Patients fulfilling criteria for AMCI [Petersen et al. 2001b]:
i. Memory impairment for age and education ii. No impairment in other cognitive domains iii. Normal social activities iv. Patient is not demented
- For the other subtypes of MCI, cognitive impairment in one or more nonmemory domain
- Sedentary lifestyle with no regular participation in physical exercise defined as two or three times a week for at least 20 minutes duration, or participation in active sport more than once a week, in the previous six months.
- Willing and able to give informed consent.
- Availability and access to safe exercise environments, such as paths or roads with sidewalks for walking or cycling.
- At low risk from serious adverse effects from increased physical activity as indicated by performance on the revised Physical activity readiness questionnaire (PARQ).
Exclusion Criteria:
Exclusion criteria for patients with MCI
- Type 1 (insulin dependent) diabetes mellitus.
- Blood pressure of 160/100 mmHg or more.
- Body weight more than 140% of ideal body weight.
- Musculoskeletal or other medical problems preventing safe participation in regular moderate intensity exercise (65-77% of predicted maximum heart rate). This will include a resting tachycardia (heart rate above 100 bpm) and history of myocardial infarction or unstable angina within the last month.
Participants with modifiable exclusion criteria will be reconsidered after successful management. Patients will be referred for medical treatment prior to commencing exercise if indicated by the PARQ and the intervention will be guided by the PARmedX.
Participants taking medications affecting heart rate will need to be on a stable dosing regime for 3 months prior to commencing in order to control for potential spurious results on fitness measures caused by these treatments.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: ThinkingFit
|
Combined physical, cognitive and social stimulation activties.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Activity Compliance
Tidsramme: Compliance with programmed activities will be assessed at the end of participation which is expected to be at 24 weeks
|
Number of participants to have completed 50% or more of the programmed activity sessions during the intervention period.
|
Compliance with programmed activities will be assessed at the end of participation which is expected to be at 24 weeks
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Cardiovascular fitness measure
Tidsramme: This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.
|
Cardiovascular fitness will be measured with a modified Siconolfi Step Test.
|
This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.
|
Cognitive measures
Tidsramme: This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.
|
Participants will complete the following cognitive measures:
|
This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.
|
Measures of quality of life and everyday activities
Tidsramme: This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.
|
Quality of life will be measured on the World Health Organization Quality of Life (WHOQOL) - BREF and change in every day activities on the Alzheimer's Disease Cooperative Study MCI Activities of Daily Living Scale (ADCS-MCI-ADL)
|
This will be measured at the start, after the control period (12 weeks) and after completion of the activity interventions at around 24 weeks.
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Efterforskere
- Ledende efterforsker: Martin Cleverley, North Essex Partnership Foundation NHS Trust
- Studieleder: Thomas M Dannhauser, PhD, University College London, North Essex Partnership NHS Foundation Trust
Publikationer og nyttige links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- ThinkingFit 1
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Mild kognitiv svækkelse
-
Johns Hopkins UniversityNational Institute on Aging (NIA)RekrutteringSøvnforstyrrelser | AMCI - Amnestic Mild Cognitive ImpairmentForenede Stater
-
Dart NeuroScience, LLCAfsluttetAge-Associated Memory Impairment (AAMI)Forenede Stater
-
Charité Neurocure AG FlöelUkendtAfasi | Anomi (ord-finding impairment)Tyskland
-
St. Boniface HospitalPizzey Ingredients; Canadian Agricultural PartnershipAktiv, ikke rekrutterendeHukommelse; Forstyrrelse, MildCanada
-
XtremeVRI AGAristotle University Of Thessaloniki; Klinik Hirslanden, Zurich; Greek Alzheimer...AfsluttetSund og rask | Mild kognitiv svækkelse, så angivet | Mild demens
-
Aristotle University Of ThessalonikiGreek Alzheimer's Association and Related DisordersAfsluttetSund og rask | Mild kognitiv svækkelse, så angivet | Mild demens
-
Mitsubishi Tanabe Pharma America Inc.AfsluttetMild og moderat nedsat leverfunktionForenede Stater
-
Maastricht University Medical CenterRekrutteringMild kognitiv svækkelse | Mild demens | Amnestisk mild kognitiv lidelseHolland
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital... og andre samarbejdspartnereRekrutteringAmnestisk mild kognitiv svækkelseKina
-
Immunotec Inc.RekrutteringMild kognitiv svækkelse (MCI)Canada
Kliniske forsøg med ThinkingFit programme
-
University of California, Los AngelesUniversity of California, San Francisco; Stanford University; California...Tilmelding efter invitationStress | Stress, psykologisk | Stress, følelsesmæssig | Stress, Fysiologisk | Stress reaktionForenede Stater
-
University of Maryland, BaltimoreNational Institute of Nursing Research (NINR)AfsluttetOsteoporose | Sundhedsadfærd
-
University of AlcalaRekrutteringLateral epikondylitisSpanien
-
Rush University Medical CenterUniversity of Colorado, Denver; Geisinger Clinic; University of Missouri,... og andre samarbejdspartnereAktiv, ikke rekrutterende
-
University of CagliariSuspenderet
-
Rhode Island HospitalState of Rhode Island Department of Health; Providence Public School District og andre samarbejdspartnereAktiv, ikke rekrutterende
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... og andre samarbejdspartnereAktiv, ikke rekrutterendeOverernæring | Ernæringsforstyrrelser | Overvægtig | Kropsvægt | Pædiatrisk fedme | Ændringer i kropsvægt | Fedme hos børn | Vægtøgning | Teenagers fedme | Fedme, barndom | Overvægt og fedme | Overvægt eller fedme | Overvægtige ungeForenede Stater
-
University of South CarolinaNational Heart, Lung, and Blood Institute (NHLBI)Afsluttet
-
October 6 UniversityRekruttering
-
GERCOR - Multidisciplinary Oncology Cooperative...Aktiv, ikke rekrutterendeMetastatisk bugspytkirtelkræft | Uoprettelig lokalt avanceret kræftFrankrig